Institutional investors purchased a net $180.2 thousand shares of TARO during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 12.42% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
UBS FINANCIAL SERVICES, INC. Bought 44.9 Thousand shares of Taro Pharmaceutical Indus...
EMPIRICAL FINANCE LLC Bought 550.00 shares of Taro Pharmaceutical Indus...